Education
About Us
Working with TipRanks
Follow Us
CureVac (CVAC)
NASDAQ:CVAC
Total Valuation
CureVac has a market cap or net worth of $1.22B. The enterprise value is $306.49M.
Market Cap$1.22B
Enterprise Value$306.49M
Share Statistics
CureVac has 225,172,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding225,172,740
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
CureVac’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 20.52%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)20.52%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee648.70K
Profits Per Employee231.37K
Employee Count825
Asset Turnover0.67
Inventory Turnover195.62
Valuation Ratios
The current PE Ratio of CureVac is 6.0. CureVac’s PEG ratio is ―.
PE Ratio6.0
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.06
Price to FCF0.00
Price to Operating Cash Flow6.69
PEG Ratio―
Income Statement
In the last 12 months, CureVac had revenue of 535.18M and earned 162.19M in profits. Earnings per share was 0.72.
Revenue535.18M
Gross Profit429.35M
Operating Income177.68M
Pretax Income190.88M
Net Income162.19M
EBITDA209.69M
Earnings Per Share (EPS)0.72
Cash Flow
In the last 12 months, operating cash flow was 157.03M and capital expenditures -13.86M, giving a free cash flow of 143.51M billion.
Operating Cash Flow157.03M
Free Cash Flow143.51M
Free Cash Flow per Share0.64
Dividends & Yields
CureVac pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.25
52-Week Price Change70.66%
50-Day Moving Average5.12
200-Day Moving Average3.69
Relative Strength Index (RSI)56.80
Average Volume (3m)828.69K
Important Dates
CureVac upcoming earnings date is Aug 14, 2025, Before Open (Confirmed).
Last Earnings DateMay 20, 2025
Next Earnings DateAug 14, 2025
Ex-Dividend Date―
Financial Position
CureVac as a current ratio of 7.28, with Debt / Equity ratio of 5.78%
Current Ratio7.28
Quick Ratio7.27
Debt to Market Cap0.00
Net Debt to EBITDA-2.11
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CureVac has paid 28.70M in taxes.
Income Tax28.70M
Effective Tax Rate0.15
Enterprise Valuation
CureVac EV to EBITDA ratio is 1.41, with an EV/FCF ratio of 3.55.
EV to Sales0.55
EV to EBITDA1.41
EV to Free Cash Flow3.55
EV to Operating Cash Flow2.91
Balance Sheet
CureVac has $442.09M in cash and marketable securities with $37.38M in debt, giving a net cash position of -$404.71M billion.
Cash & Marketable Securities$442.09M
Total Debt$37.38M
Net Cash-$404.71M
Net Cash Per Share-$1.80
Tangible Book Value Per Share$2.99
Margins
Gross margin is 87.59%, with operating margin of 33.20%, and net profit margin of 30.30%.
Gross Margin87.59%
Operating Margin33.20%
Pretax Margin35.67%
Net Profit Margin30.30%
EBITDA Margin39.18%
EBIT Margin35.67%
Analyst Forecast
The average price target for CureVac is $4.17, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$4.17
Price Target Upside-22.92% Downside
Analyst ConsensusHold
Analyst Count5
Revenue Growth Forecast799.36%
EPS Growth Forecast―